Biocon Limited has informed the Exchange regarding a press release dated February 09, 2024, titled "Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab".
Biocon Limited has informed the Exchange regarding a press release dated February 09, 2024, titled "Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab".